FlyteHealth key facts
as of Oct 2026- Developer of medical technology software and clinical services designed to transform the perception and treatment of obesity.
- FlyteHealth is valued at approximately $90.0M as of Oct 2026 (last reported valuation).
- It has raised $49.9M; the latest was Later Stage VC ($5.2M) in Nov 2025.
- Notable investors include Connecticut Innovations, The Venture Collective, 25madison, Hearst Ventures, Amplifyher Ventures — 14 tracked in total.
- Status: Privately Held (backing).
FlyteHealth's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch FlyteHealth: the Monday email on marks, rounds and moves
FlyteHealth funding rounds
No funding rounds for FlyteHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs FlyteHealth
14+FlyteHealth valuation
FlyteHealth's last reported valuation was $90 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
FlyteHealth investors
14 investors are on record for FlyteHealth, including Connecticut Innovations, The Venture Collective, 25madison and Hearst Ventures. By type, the record holds 5 venture capital firms and 1 angel investor.
About FlyteHealth
Developer of medical technology software and clinical services designed to transform the perception and treatment of obesity. The company's software helps to diagnose obesity-related diseases and provides an evaluation of each patient and customized recommendations for treatment and ongoing care, also integrates, tracks, and manages lab data and pharmacotherapy recommendations, enabling medical professionals to diagnose patients at high risk of developing metabolic complications due to their weight.
- Sector
- Healthcare
- HQ
- New Canaan, CT, United States
- Founded
- 2018
- Employees
- 93
- Website
- flytehealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.